Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Immuneering Stock News

IMRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.25

At close: Apr 16 EDT

$1.25

0.000.00%

Pre-Market: 4:00 PM EDT

Immuneering (IMRX) Forecast

News

Earnings Immuneering (IMRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Immuneering Stock News | NASDAQ:IMRX | Benzinga

Get the latest news on Immuneering stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Immuneering performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 10, 2025

Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - 6 days ago

Monday, March 24, 2025

Chardan Capital Maintains Buy on Immuneering,...
Benzinga Newsdesk - Mar 24, 2025, 7:43AM

Friday, March 21, 2025

Immuneering shares are trading higher. Needha...
Benzinga Newsdesk - Mar 21, 2025, 2:01PM
Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Mar 21, 2025, 8:57AM

Thursday, March 20, 2025

Immuneering Q4 EPS $(0.58) Misses $(0.46) Est...
Benzinga Newsdesk - Mar 20, 2025, 4:19PM

Thursday, February 06, 2025

Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Feb 6, 2025, 12:59PM
Immuneering Announced A Clinical Supply Agree...
Benzinga Newsdesk - Feb 6, 2025, 7:14AM

Monday, January 13, 2025

Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Jan 13, 2025, 11:08AM
Immuneering Announces 50% ORR In Phase 2a Wit...
Benzinga Newsdesk - Jan 13, 2025, 8:48AM

Wednesday, January 08, 2025

Chardan Capital Maintains Buy on Immuneering,...
Benzinga Newsdesk - Jan 8, 2025, 6:30AM

Tuesday, January 07, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jan 7, 2025, 4:06PM
Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Jan 7, 2025, 11:13AM
Why Is Immuneering Stock Trading Higher On Tuesday?
Vandana Singh - Jan 7, 2025, 9:28AM
Immuneering shares are trading higher after t...
Benzinga Newsdesk - Jan 7, 2025, 8:47AM
Immuneering Releases Interim Data From Phase ...
Benzinga Newsdesk - Jan 7, 2025, 8:45AM

Thursday, December 19, 2024

Immuneering shares are trading higher after t...
Benzinga Newsdesk - Dec 19, 2024, 3:10PM
Immuneering Launches Pancreatic Cancer Adviso...
Benzinga Newsdesk - Dec 19, 2024, 8:09AM

Tuesday, December 17, 2024

Immuneering To Present Phase 2a Trial Data Fo...
Benzinga Newsdesk - Dec 17, 2024, 8:03AM

Friday, December 13, 2024

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
Vandana Singh - Dec 13, 2024, 2:10PM

Thursday, December 12, 2024

Immuneering shares are trading higher after t...
Benzinga Newsdesk - Dec 12, 2024, 8:01AM
Immuneering Announces FDA Fast Track Designat...
Benzinga Newsdesk - Dec 12, 2024, 8:01AM

Wednesday, November 20, 2024

Chardan Capital Maintains Buy on Immuneering,...
Benzinga Newsdesk - Nov 20, 2024, 5:54PM

Thursday, November 14, 2024

Immuneering shares are trading higher after t...
Benzinga Newsdesk - Nov 14, 2024, 8:55AM
Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Nov 14, 2024, 5:20AM

Wednesday, November 13, 2024

Immuneering Q3 2024 GAAP EPS $(0.49) Beats $(...
Benzinga Newsdesk - Nov 13, 2024, 4:10PM

Friday, October 18, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights - Oct 18, 2024, 4:30PM

Tuesday, October 15, 2024

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Oct 15, 2024, 12:32PM
Immuneering shares are trading higher after t...
Benzinga Newsdesk - Oct 15, 2024, 8:55AM
Immuneering Granted FDA Orphan Drug Designati...
Benzinga Newsdesk - Oct 15, 2024, 8:11AM

Wednesday, October 02, 2024

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
Chris Katje - Oct 2, 2024, 4:18PM

Friday, September 13, 2024

Why Is Nanocap Immuneering Stock Trading Higher On Friday?
Vandana Singh - Sep 13, 2024, 8:14AM
Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Sep 13, 2024, 5:42AM

Thursday, September 12, 2024

Immuneering shares are trading higher after t...
Benzinga Newsdesk - Sep 12, 2024, 4:09PM
Immuneering Announces Initial Phase 2a Data F...
Benzinga Newsdesk - Sep 12, 2024, 4:09PM

Wednesday, August 07, 2024

Chardan Capital Maintains Buy on Immuneering,...
Benzinga Newsdesk - Aug 7, 2024, 7:57AM
5Needham Reiterates Buy on Immuneering, Maint...
Benzinga Newsdesk - Aug 7, 2024, 7:46AM

Tuesday, August 06, 2024

Immuneering Q2 EPS $(0.47) Beats $(0.52) Esti...
Benzinga Newsdesk - Aug 6, 2024, 5:06PM

Thursday, August 01, 2024

Nasdaq Surges 1%; Meta Posts Upbeat Earnings
Avi Kapoor - Aug 1, 2024, 10:15AM
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Aug 1, 2024, 8:32AM
Market-Moving News for August 1st
Benzinga Newsdesk - Aug 1, 2024, 8:21AM
Immuneering shares are trading higher after t...
Benzinga Newsdesk - Aug 1, 2024, 7:46AM

Wednesday, July 31, 2024

Immuneering shares are trading higher after t...
Benzinga Newsdesk - Jul 31, 2024, 5:11PM
Immuneering Granted FDA Fast Track Designatio...
Benzinga Newsdesk - Jul 31, 2024, 4:59PM

Tuesday, June 11, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jun 11, 2024, 4:31PM

Wednesday, May 08, 2024

Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - May 8, 2024, 5:58AM

Tuesday, May 07, 2024

Immuneering Q1 EPS $(0.49) Misses $(0.46) Est...
Benzinga Newsdesk - May 7, 2024, 5:02PM

Friday, April 12, 2024

Needham Reiterates Buy on Immuneering, Mainta...
Benzinga Newsdesk - Apr 12, 2024, 6:33AM

Tuesday, April 09, 2024

Immuneering Presented Preclinical Data At AAC...
Benzinga Newsdesk - Apr 9, 2024, 12:04PM

Thursday, March 28, 2024

Immuneering shares are trading higher. The co...
Benzinga Newsdesk - Mar 28, 2024, 11:45AM

Wednesday, March 27, 2024

Immuneering Announces First Patient Dosed In Its Phase 1/2a Trial Of IMM-6-415 To Treat Advanced Solid Tumors With RAF Or RAS Mutations
Happy Mohamed - Mar 27, 2024, 8:08AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved